Regulatory: Patent office secrecy orders for commercial inventions may stifle development
In 1999, Congress passed the American Inventors Protection Act (AIPA), which provided, among other provisions, that U.S. patent applications would be published 18 months after filing.
January 23, 2013 at 06:38 AM
5 minute read
The original version of this story was published on Law.com
In 1999, Congress passed the American Inventors Protection Act (AIPA), which provided, among other provisions, that U.S. patent applications would be published 18 months after filing. This provision was designed to bring the U.S. patent process into harmonization with patent procedures in other major world markets, including Europe and Japan. It was also said to be necessary in order to prevent inventors from intentionally delaying issuance of patents until markets developed, a scheme often described as “submarine” patenting.
One issue that has arisen as a result of the 18 month publication provision is that inventions are published long before enforceable patents are issued by the U.S. Patent Office (PTO). The average pendency of a U.S. patent application was 33.7 months in 2011. As a result, on average, there was a 15.7 month gap between worldwide disclosure of the invention and the issuance of enforceable patent rights protecting that invention.
Last year a congressional committee directed the PTO to study the possibility of special treatment for patents that potentially affect “economic security.” Congress' stated purpose was to “ensure that the United States receives the first benefits of innovations conceived within this country, so as to promote domestic development, further innovation and continued economic expansion.”
The suggested mechanism is similar to that used to control publication of patent applications for sensitive defense and nuclear technology. Patent applications which may include such sensitive information are reviewed by a panel of military and defense agencies. If it is determined the patent application includes sensitive material, the PTO issues a “secrecy order.” The secrecy order prevents publication of the application and tightly restricts an applicants' right to file for patents in foreign countries. Secrecy orders also work hand-in-hand with other export control mechanisms, preventing sale and commercialization of inventions that have defense implications, especially outside the U.S.
Secrecy orders are indefinite in length. A patent does not issue while a secrecy order is in effect. There are currently about 5,000 patent applications under secrecy order. Since 2000, fewer than 100 secrecy orders have been rescinded in any one year. As a practical matter, most of the applications under secrecy order are likely owned by defense contractors whose sole customer is the U.S. government. Therefore, the existence of a secrecy order is not a significant detriment to patent owners in those cases.
But what would happen if secrecy orders were expanded to include economic security. Which inventions would be determined to affect economic security? Would they include Apple's next i-device, a biotech cure for a form of cancer or perhaps new energy development technology? Could the PTO arbitrarily issue secrecy orders, perhaps to hamper the development of technologies not favored by the government?
On April 20, 2012, the PTO requested comments on the proposal to screen patent applications for economic security effects. Industry organizations, patent attorney organizations, companies and universities responded. The comments were overwhelmingly negative, although there were some supporters of the concept. It was pointed out that economic secrecy orders would significantly impair the commercialization of the product. Such rules would have the perverse effect of more seriously impacting the most valuable and widespread technologies. Multiple commentators pointed out the rules would hamstring U.S. interests in the global marketplace because patent filing and disclosure outside the U.S. would be prevented or limited.
One purpose of the patent system is to encourage disclosure of inventions in exchange for the issuance of patent rights which are limited in time. Inventors faced with the possibility of having valuable rights locked up by a secrecy order would be more likely to simply maintain their technology as a trade secret. This would be a detriment to technology development and undercut a key purpose of the patent system.
It was also pointed out a secrecy order regime would work against the original purpose of the AIPA, namely global harmonization. This proposed procedure is out of the global mainstream. A Japanese group raised the specter of a return of submarine patents, this time caused by placing patents under secrecy order for a period of time and then allowing them to issue when a market is fully developed.
There are already in place procedures to avoid patent publication. This proposal would replace a strategic choice by the inventor with a determination by government agencies, all to the detriment of commercialization of the invention.
The most thorough comment in support of the proposal was by “Anonymous.” This commentator believes economic security is just as important as national security and expressed a belief that controlling export of technology is key.
As pointed out by multiple commentators, the stated problem could be solved if the PTO could issue patents closer to the 18-month publication date. It was suggested that perhaps resources should be spent in increasing PTO effectiveness rather than imposing another regulatory scheme on the technology community.
The PTO continues to “study” the issue.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View AllWhy Seemingly Simple Off-Channel Communication Rules Still Vex Finance Industry
5 minute readTrending Stories
- 1The Law Firm Disrupted: Playing the Talent Game to Win
- 2Preparing Your Law Firm for 2025: Smart Ways to Embrace AI & Other Technologies
- 3BD Settles Thousands of Bard Hernia Mesh Lawsuits
- 4GlaxoSmithKline Settles Most Zantac Lawsuits for $2.2B
- 5A&O Shearman Adopts 3-Level Lockstep Pay Model Amid Shift to All-Equity Partnership
Who Got The Work
Blank Rome partner Andrew T. Hambelton has stepped in to defend Fragrancenet.com in a pending trademark infringement lawsuit. The case, filed Aug. 29 in New York Southern District Court by the Blakely Law Group, targets the defendants for allegedly selling counterfeit fragrance products. The case, assigned to U.S. District Judge Lorna G. Schofield, is 1:24-cv-06521, Abercrombie & Fitch Trading Co. v. Quester (US) Enterprises, Inc. et al.
Who Got The Work
Davis Polk & Wardwell partners Mari Grace and Edmund Polubinski III have entered appearances for Australia-based Bitcoin-mining company Iris Energy and other defendants in a pending securities class action. The action, filed Oct. 7 in New York Eastern District Court by the Rosen Law Firm, contends that the defendants concealed the inadequacy of the company's site in Childress County, Texas, including it being 'ill-equipped' and unable to operate the company's proprietary design. The case, assigned to U.S. District Judge Peggy Kuo, is 1:24-cv-07046, Williams-Israel v. Iris Energy Limited et al.
Who Got The Work
Ryan S. Stippich of Reinhart Boerner Van Deuren has entered an appearance for biopharmaceutical company Veru Inc. and other defendants in a pending shareholder derivative lawsuit. The action, filed Sept. 30 in Wisconsin Western District Court by the Brown Law Firm on behalf of June Ovadias, accuses the defendant of failing to disclose that small sample sizes and other issues rendered it unlikely that the FDA would grant Emergency Use Authorization for the cancer drug candidate sabizabulin as a potential treatment for COVID-19. The case, assigned to U.S. District Judge William M. Conley, is 3:24-cv-00676, Ovadias, June v. Steiner, Mitchell et al.
Who Got The Work
Holland & Knight partners Cynthia A. Gierhart and Thomas Willcox Brooke have entered appearances for Pakistani American Political Action Committee and Rao Kamran Ali in a pending trademark infringement lawsuit. The action, filed Sept. 24 in District of Columbia District Court by Jackson Walker on behalf of Pakistani American Public Affairs Committee, accuses the defendants of using a mark that's confusingly similar to the plaintiff's 'Pak-Pac' marks without authorization. The case, assigned to U.S. District Judge Randolph D. Moss, is 1:24-cv-02727, Pakistani American Public Affairs Committee v. Pakistani American Political Action Committee et al.
Who Got The Work
Lauren M. Rosenberg and Yonatan Even of Cravath, Swaine & Moore have stepped in to represent Israel-based Oddity Tech Ltd. in a pending securities class action. The case, filed Aug. 30 in New York Southern District Court by Pomerantz LLP and Holzer & Holzer, contends that the defendant made materially misleading statements regarding the capability of Oddity's AI technology and ongoing civil litigation, resulting in the artifical inflation of the market price of Oddity's securities. The case, assigned to U.S. District Judge Margaret M. Garnett, is 1:24-cv-06571, Hoare v. Oddity Tech Ltd. et al.
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250